Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E N Prystowsky

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Reviews in Cardiovascular Medicine|November 20, 2002
Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillatorE N Prystowsky
The American Journal of Cardiology|November 21, 2000
Screening and therapy for patients with nonsustained ventricular tachycardiaE N Prystowsky
The American Journal of Cardiology|April 9, 1992
Effects of bepridil on cardiac electrophysiologic propertiesE N Prystowsky
Herz|June 1, 1983
Pharmacologic therapy of tachyarrhythmias in patients with Wolff-Parkinson-White syndromeE N Prystowsky
Annals of Internal Medicine|February 1, 1997
Management of atrial fibrillation: simplicity surrounded by controversyE N Prystowsky
The American Journal of Cardiology|January 15, 1988
Antiarrhythmic therapy for asymptomatic ventricular arrhythmiasE N Prystowsky
Journal of Cardiovascular Electrophysiology|January 5, 2002
When technology exceeds knowledge, is success a reasonable expectation?E N Prystowsky
Angiology|July 1, 1988
Issues in the selection of an antiarrhythmic agentE N Prystowsky
The American Journal of Cardiology|August 3, 2000
Cardioversion of atrial fibrillation to sinus rhythm: who, when, how, and why?E N Prystowsky
Pacing and Clinical Electrophysiology : PACE|April 1, 1992
Antiarrhythmic drug therapy as an adjunct or alternative to an implantable cardioverter defibrillatorE N Prystowsky
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Reviews in Cardiovascular Medicine|November 20, 2002
Primary and secondary prevention of sudden cardiac death: the role of the implantable cardioverter defibrillatorE N Prystowsky
The American Journal of Cardiology|November 21, 2000
Screening and therapy for patients with nonsustained ventricular tachycardiaE N Prystowsky
The American Journal of Cardiology|April 9, 1992
Effects of bepridil on cardiac electrophysiologic propertiesE N Prystowsky
Herz|June 1, 1983
Pharmacologic therapy of tachyarrhythmias in patients with Wolff-Parkinson-White syndromeE N Prystowsky
Annals of Internal Medicine|February 1, 1997
Management of atrial fibrillation: simplicity surrounded by controversyE N Prystowsky
The American Journal of Cardiology|January 15, 1988
Antiarrhythmic therapy for asymptomatic ventricular arrhythmiasE N Prystowsky
Journal of Cardiovascular Electrophysiology|January 5, 2002
When technology exceeds knowledge, is success a reasonable expectation?E N Prystowsky
Angiology|July 1, 1988
Issues in the selection of an antiarrhythmic agentE N Prystowsky
The American Journal of Cardiology|August 3, 2000
Cardioversion of atrial fibrillation to sinus rhythm: who, when, how, and why?E N Prystowsky
Pacing and Clinical Electrophysiology : PACE|April 1, 1992
Antiarrhythmic drug therapy as an adjunct or alternative to an implantable cardioverter defibrillatorE N Prystowsky
Pageof 18